首页|核转录因子红系2相关因子2在肝缺血再灌注损伤中的作用及麻醉药物干预的研究进展

核转录因子红系2相关因子2在肝缺血再灌注损伤中的作用及麻醉药物干预的研究进展

扫码查看
肝缺血再灌注损伤(IRI)是一种常见的肝脏损伤类型,严重影响患者预后.核转录因子红系 2 相关因子 2(Nrf2)是一种重要的转录因子,参与多种细胞生理活动.研究表明,Nrf2在肝脏IRI中起重要调控作用,激活Nrf2及相关通路能够清除活性氧,减少氧化应激损伤,从而减轻肝脏IRI.近年来,麻醉药物调控Nrf2信号通路在基础实验和临床试验中减轻肝脏IRI均取得一定成果,但仍处于实验阶段.本文通过分析近年来麻醉药物相关研究进展,对Nrf2在肝脏IRI中的作用及机制进行综述,以期为肝脏IRI的防治提供新方向.
Research progress on the role of nuclear factor-erythroid 2-related factor 2 in hepatic ischemia-reperfusion injury and the intervention of anesthetic drugs
Hepatic ischemia-reperfusion injury(IRI)is a common type of liver injury that severely affects patient prognosis.Nuclear factor-erythroid 2-related factor 2(Nrf2)is an important transcription factor involved in a variety of cellular physiological activities.Studies have shown that Nrf2 plays a significant regulatory role in hepatic IRI,and activation of Nrf2 and related pathways can scavenge reactive oxygen species,reduce oxidative stress injury,and thus alleviate hepatic IRI.In recent years,the modulation of Nrf2 signaling pathway by anesthesia drugs has achieved some results in alleviating hepatic IRI in basic experiments and clinical trials,but it is still in experimental stage.This paper reviews the role and mechanism of Nrf2 in hepatic IRI by analyzing the research progress related to anesthetic drugs in recent years,with the aim of providing a new direction for the prevention and treatment of hepatic IRI.

Hepatic ischemia-reperfusion injuryNuclear factor-erythroid 2-related factor 2Oxidative stressAnesthetic drugs

孟千港、肖梦柔、赵媛

展开 >

湖南师范大学附属第一医院麻醉科,湖南长沙 410005

肝缺血再灌注 核转录因子红系相关因子2 氧化应激 麻醉药物

湖南省自然科学基金青年基金湖南省卫生健康委科研项目

2018JJ3291202104111288

2024

中国医药导报
中国医学科学院

中国医药导报

CSTPCD
影响因子:1.759
ISSN:1673-7210
年,卷(期):2024.21(7)
  • 32